FDA Investigator Tracy R Ball

Tracy R Ball has conducted inspections on 287 sites in 7 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

287

Last Inspection Date:

27 Jun 2024

Investigator Role:

FDA Investigator

Redica ID:

100001492

Countries of Inspections:

United States of America, Argentina, Denmark, Poland, Canada, United Kingdom of Great Britain and Northern Ireland, Spain

FDA Investigators that have inspected at least one site in common with Tracy R Ball:

Aaron P Wozniak, Abdur Rashid, Adam R Cooke, Alaric C Denton, Alphonso A Haupt, III, Althea A Williams, Amy H Ruble, Andrace L Deyampert, Andrea L Williams Jones, Angelica M Hernandez, Ann B Borromeo, Anna M Brannen, Anthony J Grace, Arthur G Hurst, Barbara A Rusin, Barbara M Frazier, Barbara T Carmichael, Betsy C Galliher, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brett D Weed, Brett Weed, Brian A Graves, Brian R Yaun, Burnell M Henry, Cara Fiore, PhD, Cara M Minelli, Carl E Lovrich, Carlos A Ortiz, Carol F Robinson, Cassandra L Abellard, CDR Thomas R Berry, PPh, Cheryl A Grandinetti, Cheryl D Barton, Cheryl Love Harris, Chris Alexander, Christine M O'leary, Christopher S Keating, Claudette D Brooks, Constance Y Fears, Cordelia J Brammer, Cynthia F Kleppinger, MD, Daphne Santiago, PhD, David E Lowe, David T Glover, David Williams, Dawn M Braswell, Deborah A Greco, Deborah M Trout, Debra J Tucker, Dellarese L Herbert, Derek C Price, Devaughn Edwards, Deyaa Shaheen, Diane Hall, Doretha M Tonkins, Doretha M Wilson, Douglas L Page, Dr. Jason R Caballero, Dr. Koffi A Amegadje, Edecia A Richards, Edward Deberry, Edward Lukeman, Eileen J Bannerman, Eileen T Monaghan, Eric S Weilage, Ernest H Blackwood, Esra Toussaint, Frank Wackes, Gabriel R Mclemore, Gamal A Norton, Gates E Raynor, George G Calafactor, Gideon N Esuzor, Hai Lient Phung, Harshal J Desai, Helen R Bester, Hristu B Chepa, Ibad U Khan, Jacqueline Mdiaz Albertini, James P Lewis, Jr, Janet B Gray, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeff M Uriarte, Jennifer D Hollstrom, Jessica A Stephens, Jessica D Weber, Jessica Fields, Jianyang Wang, Jie He, Joanne T Gabay, John E Aghadia, Johnson, Jonathan G Swoboda, Joseph F Owens, Joyce A Rockwell, Kara D Dobbin, Kassa Ayalew, MD, Katelynn J Rollins, Kathleen D Culver, Kemejumaka N Opara, Kenneth L Smalls, Kevin J Matthews, Khalid M Khan, Kimberly Cdelk Brooks, Kip J Hanks, Lareese K Thomas, Larry K Hampton, Lauryl A Smith, Leon L Crawley, Leslie W Gilbert, Lewis K Antwi, Lillie D Witcher, Lisa P Oakes, Lorenzo Jones, LT Daveta L Bailey, LT Tamara J Henderson, Mancia R Walker, Marie F Morin, Marla A Cassidy, Mary Alice Papadimitriou, Mary T Carden, Megan T Ziegler, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michelle D Haamid, Michelle L Jones, Morrell, Nancy E Fontaine, Nicholas M Smith, Nicole K Trudel, Nicole M Bell, Nigel L Hirth, Noreen Muñiz, Omotunde O Osunsanmi, Pamela L Velez Vega, Paul W Moy, Paula J Bretz, Penny H Mccarver, Philip Campbell, Rachael A Moliver, Rachael L Cook, Rachel M Skeete, Randy D Baxter, Randy L Clarida, Rashard A Knight, Rashonda N Rucker, Reba A Gates, Rebecca Rodriguez, Regan T Harp, Richard J Bashay, Richard L Garcia, Robert C Coleman, Robert L Lewis, Jr, Robin N Goins, Ronit Jolles Mazor, Rosia E Nesbitt, Samantha J Bradley, Sarah L Holliday, Scott E Norris, Seneca D Toms, Sereen Gmorgan Murray, Sharna D Pratt, Sherri J Jackson, Simone E Pitts, Sonya M Edmonds, Steven D Banks, Susan M Jackson, Susan O Oladeji, Tajah L Blackburn, Tamara M Casselman, Thomas D Clarida, Thomas W Nojek, Tracy L Ramseur, Trang N Cox, Tyrico K English, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Viviana Matta, William P Tonkins, Xiomara Copeland, Yiyue Zhang (nmi), PhD, Youmin Wang

Tracy R Ball's Documents

Publish Date	Document Type	Title
September, 2009	FDA 483	CSL Plasma, Inc - Form 483, 2009-09-18
May, 2002	FDA 483	Frenette, Gary MD - Form 483, 2002-05-28
July, 2009	FDA 483	Terry Arnold, M.D. - Form 483, 2009-07-22
June, 2016	EIR	Mohammed Alhatou - EIR, 2016-06-16
December, 2003	FDA 483 Response	Ei, LLC - Form 483R, 2004-01-20
February, 2001	EIR	Leiner Health Product, Llc - EIR, 2001-02-01
December, 2012	EIR	Custom Analytics LLC - EIR, 2012-12-11
July, 2001	EIR	McKesson Corporation - EIR, 2001-07-02
January, 2012	EIR	Chelsea Therapeutics Inc - EIR, 2012-01-19
August, 2004	FDA 483	SC Johnson Professional USA, Inc. - Form 483, 2004-08-18
February, 2001	FDA 483	Leiner Health Product, Llc - Form 483, 2001-02-01
February, 2018	EIR	GW RESEARCH LTD - EIR, 2018-02-02
March, 2002	FDA 483	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2002-03-22
June, 2002	EIR	Ei, LLC - EIR, 2002-06-14
September, 2013	FDA 483	SC Johnson Professional USA, Inc. - Form 483, 2013-09-24
June, 2000	FDA 483	Heyder, Albrecht - Form 483, 2000-06-10
November, 2000	EIR	Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-11-21
January, 2005	EIR	Ei, LLC - EIR, 2005-01-14
February, 2000	EIR	Marc T. Silver, MD - EIR, 2000-02-01
April, 2004	FDA 483	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2004-04-02
June, 2000	EIR	Heyder, Albrecht - EIR, 2000-06-09
July, 2011	EIR	SpecGx LLC - EIR, 2011-07-21
August, 2000	EIR	Rotberg, Michael - EIR, 2000-08-03
October, 2015	EIR	Patheon Softgels Inc. - EIR, 2015-10-05
December, 2003	FDA 483	Ei, LLC - Form 483, 2003-12-23
October, 2002	EIR	GlaxoSmithKline LLC - EIR, 2002-10-17
October, 2000	FDA 483	American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26
September, 2012	EIR	Akesis, LLC - EIR, 2012-09-14
November, 2000	FDA 483	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-11-21
March, 2024	FDA 483	Wake Forest University Health Sciences RDRC - Form 483, 2024-03-07
June, 2000	EIR	Leiner Health Product, Llc - EIR, 2000-06-01
September, 2003	FDA 483	The Ritedose Corporation - Form 483, 2003-09-12
January, 2000	EIR	Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-01-14
March, 2002	EIR	Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-03-22
November, 2015	FDA 483	Duke Clinical Research Institute - Form 483, 2015-11-04
September, 2013	EIR	SC Johnson Professional USA, Inc. - EIR, 2013-09-24
February, 2006	FDA 483	Marlin Company, Inc. - Form 483, 2006-02-02
April, 2012	FDA 483	Marlin Company, Inc. - Form 483, 2012-04-18
February, 2002	EIR	Albemarle Corporation - EIR, 2002-02-14
April, 2004	FDA 483 Response	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2004-04-29
December, 2002	EIR	Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-12-12
December, 2003	EIR	Ei, LLC - EIR, 2003-12-23
March, 2007	FDA 483 Response	Leiner Health Product, Llc - Form 483R, 2007-04-09
July, 2003	FDA 483	Carolina Medical Inc - Form 483, 2003-07-18
January, 2000	FDA 483	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-01-14
August, 2002	EIR	Crain, Jack L., M.D. - Clinical Investigator - EIR, 2002-08-14
October, 2003	EIR	McKesson Corporation - EIR, 2003-10-08
February, 2002	EIR	Casat, Charles D., MD - Clinical Investigator - EIR, 2002-02-26
September, 2001	EIR	Walter D. Holder, MD Clinical Investigator - EIR, 2001-09-06
July, 2001	EIR	Frenette, Gary MD - EIR, 2001-07-27
March, 2007	FDA 483	Leiner Health Product, Llc - Form 483, 2007-03-16
September, 2001	FDA 483	Walter D. Holder, MD Clinical Investigator - Form 483, 2001-09-06
November, 2001	FDA 483	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2001-11-09
February, 2002	FDA 483	Dr. Charles D. Casat - Clinical Investigator - Form 483, 2002-02-26
April, 2017	EIR	BioAgilytix Labs - EIR, 2017-04-26
July, 2001	FDA 483	Frenette, Gary MD - Form 483, 2001-07-27
November, 2001	EIR	Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2001-11-09
November, 2000	FDA 483 Response	Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2000-11-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more